Tekmira Pharmaceuticals (ABUS) – Aktiekurs og nyheder – Google Finans

Finans

StartABUS • NASDAQ

Tekmira Pharmaceuticals

4,60 $

Efter lukketid:

4,65 $

(1,09 %)+0,050

Lukket: 25. feb., 19.54.40 GMT-5 · USD · NASDAQ · Ansvarsfraskrivelse

AktieVærdipapir børsnoteret i USAHovedkvarter i USA

Seneste lukkekurs

4,46 $

Dagsinterval

4,50 $ - 4,69 $

Årsinterval

2,71 $ - 5,10 $

Markedsværdi

884,69 mio. USD

Gns. volumen

1,88 mio.

P/E-værdi

-

Udbytteprocent

-

Primær børs

NASDAQ

Markedsnyheder

for 8 timer siden

S&P 500’s 20-day range squeeze near highs hints at imminent shift

for 3 timer siden

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

for 7 minutter siden

Nasdaq 100, S&P 500 Outlook: Nvidia Strength Runs Into Resistance

for 32 minutter siden

Bloomin' Brands (BLMN) Q4 EPS Loss Keeps Margin Concerns In Focus For Bulls And Bears

for 9 timer siden

March 2027 Options Now Available For Realty Income (O)

for 4 timer siden

Rand Capital Announces $0.29 per Share Cash Dividend for First Quarter 2026

Om

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia

Administrerende direktør

William H. Collier

Grundlagt

2007

Hovedkvarter

Warminster Township Pennsylvania
USA

Website

Ansatte

44

Søgning

Ryd søgning

Luk søgning

Google-apps

Hovedmenu